Exelixis
(NASDAQ:EXEL)
$22.23
0.11[0.50%]
At close: May 2
$22.23
0[0.00%]
PreMarket: 6:27PM EDT
Q1 2024 Earnings were released on Tue Apr 30th, after the market close
The most recent conference call was at 17:00 PM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary

Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 2.345M
Day Range- - -
52 Wk Range18.520 - 24.340
Market Cap$6.475B
P/E Ratio34.031
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
3.13%
Days to Cover3.08

Recent News

Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Avi Kapoor
Bristol Myers, Exelixis Reveal 4-Year Follow-Up Results From Cancer Treatment Study
Bristol Myers Squibb & Exelixis Inc revealed four-year follow-up results from CheckMate -9ER trial.
Vandana Singh
Jim Cramer Likes This 'Well-Run' Airline, Says This Entertainment Stock Has 'Balance Sheet From Hell'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Franco-Nevada Corporation (NYSE: FNV) is a "great diversified
Avi Kapoor
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EXEL
IMVT

FAQ

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Exelixis's (EXEL) competitors?

A

Other companies in Exelixis’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Exelixis (EXEL) stock?

A

The latest price target for Exelixis (NASDAQ: EXEL) was reported by TD Cowen on Wednesday, May 1, 2024. The analyst firm set a price target for 27.00 expecting EXEL to rise to within 12 months (a possible 21.46% upside). 29 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $22.23 last updated May 2, 2024 at 6:27 PM EDT.

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A

Exelixis’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch